Royal Bank of Canada Increases Abbott Laboratories (NYSE:ABT) Price Target to $128.00
Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target lifted by research analysts at Royal Bank of Canada from $119.00 to $128.00 in a research report issued on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the healthcare product maker’s stock. Royal Bank of Canada’s target price would suggest a […]
More Stories
Crew Energy (OTCMKTS:CWEGF) Trading Up 2.6% – Here’s Why
Crew Energy Inc. (OTCMKTS:CWEGF – Get Free Report) shares were up 2.6% during trading on Monday . The stock traded...
PayPal USD (PYUSD) Price Reaches $1.00 on Top Exchanges
PayPal USD (PYUSD) traded 0% higher against the U.S. dollar during the twenty-four hour period ending at 0:00 AM E.T....
TDH (NASDAQ:PETZ) Shares Down 0.8% – What’s Next?
TDH Holdings, Inc. (NASDAQ:PETZ – Get Free Report)’s share price fell 0.8% during mid-day trading on Monday . The company...
First Trust NASDAQ 100 Technology Index Fund (NASDAQ:QTEC) Stock Price Down 0.1% – Here’s What Happened
First Trust NASDAQ 100 Technology Index Fund (NASDAQ:QTEC – Get Free Report)’s stock price dropped 0.1% during trading on Monday...
Partners Group (OTCMKTS:PGPHF) Stock Price Down 0.1% – Should You Sell?
Partners Group Holding AG (OTCMKTS:PGPHF – Get Free Report)’s share price traded down 0.1% during mid-day trading on Monday ....
M&G (LON:MNG) Shares Down 0.5% – Here’s Why
M&G plc (LON:MNG – Get Free Report)’s stock price was down 0.5% during mid-day trading on Monday . The stock...